|Bid||4.68 x 0|
|Ask||4.69 x 0|
|Day's Range||4.6400 - 4.7900|
|52 Week Range||0.1550 - 6.3300|
|Beta (3Y Monthly)||N/A|
|PE Ratio (TTM)||13.53|
|Earnings Date||Feb 27, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||6.72|
Although cannabis remains federally criminalized, if more US states follow in California's footsteps, this may result in an influx of investors looking to the marijuana stock market for opportunities. Nabis Holdings (INNPF) (NAB), INSYS Therapeutics Inc (INSY), CannTrust Holdings Inc (OTC PINK: CNTTF), and Canopy Rivers Inc (OTC PINK: CNPOF) (RIV.V) are four cannabis companies picking up speed on Tuesday. Nabis Holdings (INNPF) (NAB) is a Canadian investment company focused on investing in high-quality cash flowing and strategic assets across multiple aspects of the cannabis sector primarily in the U.S. limited license states with a roadmap to expand globally.
Mugglehead says cannabis beverages are going to be the talk of 2019. Since securing its deal with Constellation Brands, Inc. (STZ), all eyes have been on Canopy Growth and what it plans to do in the beverages space. Recently, it also announced it would be injecting an additional CAD $30 million into Canopy Rivers Inc. (RIV.V), its investing arm.
Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a snapshot looking at how recent developments in the EU Parliament as well as WHO (World Health Organization) could have massive impacts on the cannabis market and which companies are preparing for this next step in the radically expanding sector. In breaking news yesterday, the European Parliament passed a resolution calling on the European Commission and EU countries to provide a legal definition and draw a clear distinction between cannabis-based medicines approved by regulatory bodies, MMJ not supported by clinical trials, and other applications of the plant.
Canopy Rivers Inc. (the “Company”) (RIV.V) will report its third quarter fiscal 2019 financial results after markets close on Wednesday February 27, 2019. The Company’s unaudited condensed interim financial statements and Management’s Discussion and Analysis for the three and nine months ended December 31, 2018 will be available on the Company’s profile on SEDAR at www.sedar.com and in the Investors section of the Company’s website at www.canopyrivers.com. Certain preliminary financial information pertaining to the Company may also be found in the financial results released by Canopy Growth Corporation (TSX: WEED, NYSE: CGC) that is currently scheduled to be released on February 14, 2019.
Precision Extraction Solutions Named Exclusive Equipment Supplier of Canapar S.r.L. DETROIT, Feb. 12, 2019 /PRNewswire/ -- Precision Extraction Solutions ("Precision"), a market leader in cannabis and hemp extraction technology, has been named the exclusive equipment supplier of Canapar S.r.L. ("Canapar") for the development and outfitting of its flagship extraction facility in Sicily, Italy. On the heels of a $25 million CAD ($20 million USD) round of financing, that included a lead investment by Canopy Rivers Inc (RIV.V), the corporate venture capital platform of Canopy Growth Corporation (TSX: WEED, NYSE: CGC), a global leader in the cannabis sector, Canapar engaged Precision for the design and manufacturing of an industrial scale hemp extraction plant.
SMITHS FALLS, ON , Feb. 7, 2019 /CNW/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (WEED.TO) (CGC) is pleased to announce that it intends to increase its total investment in Canopy Rivers Inc. ("Canopy Rivers") (RIV.V) by $30 million (CDN). The investment will be made through a private placement of subordinated voting shares in the capital of Canopy Rivers (the "Subordinate Voting Shares") concurrent with Canopy Rivers bought deal offering of Subordinate Voting Shares for gross proceeds of approximately $55 million . This investment is being co-led by CIBC Capital Markets and Eight Capital and is expected to close on or about February 27, 2019 .
Canopy Rivers Inc. (RIV.V) (“Canopy Rivers” or the “Company”) is pleased to announce that it has entered into an agreement with CIBC Capital Markets (“CIBC”) and Eight Capital (together with CIBC, the “Joint Bookrunners”), under which the Joint Bookrunners have agreed to purchase, together with a syndicate of underwriters (the “Underwriters”), 11,500,000 subordinated voting shares of the Company (the “Subordinated Voting Shares”) on a “bought deal” basis at a price of $4.80 per Subordinated Voting Share (the “Issue Price”) for gross proceeds of approximately $55.0 million (the “Bought Deal”).
In fact, analysts at Cowen say U.S. cannabis sales alone could reach $80 billion by 2030 - an increase of $5 billion from earlier estimates, and a 4% compound annual growth rate. Piper Jaffray believes the market for legal cannabis could be worth $15 billion to $50 billion a year, with global sales growing to $250 billion to $500 billion. Corporate America is quickly waking up to the opportunity with alcohol companies taking a stake in cannabis stocks.
Canopy Rivers Inc. (the “Company” or “Canopy Rivers”) (RIV.V) is pleased to announce that it has completed a subsequent $9.4 million equity investment in its portfolio company Canapar Corp. (“Canapar Canada”), the Canadian parent corporation of Canapar SrL (“Canapar Italy”), an Italy-based organic hemp production and processing platform.
Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a snapshot focusing on how the cannabis industry continues to force technology innovation as it faces new challenges with the sector’s continuing rapid growth. The cannabis industry has begun to fully affect the beverage, food, medical and pharmaceutical industries but one area cannabis has helped drive forward from inception has been the tech industry. Due to the complexity of the cannabis plant as well as the strict regulations surrounding it, technological innovations have been a “must have” for any cannabis company that hopes to expand and grow.
Canopy Rivers Inc. (the “Company” or “Canopy Rivers”) (RIV.V) is pleased to announce it has completed an equity investment in 10663522 Canada Inc., or “Herbert” (“Herbert”), a unique brand platform that focuses on the adult-use cannabis beverage and edibles market. Canopy Rivers subscribed for C$1,500,000 of preferred shares in Herbert, and received incremental warrants entitling the Company to increase its economic interest in Herbert under certain circumstances, as well as other governance-related rights. “Herbert represents an opportunity for Canopy Rivers to be invested at a very early stage in a company focused on the adult-use cannabis beverage and edible product segment,” said Narbe Alexandrian, President of Canopy Rivers.
Canopy Rivers Inc. (the “Company” or “Canopy Rivers”) (RIV.V) is pleased to provide an update on the operations of Canapar SrL (“Canapar), an Italian-based hemp production and processing platform and subsidiary of portfolio company, Canapar Corp. Yesterday evening, in Ragusa, Sicily, Canapar hosted a ribbon cutting ceremony for its new cannabidiol (“CBD”) extraction and processing facility. When completed in Fall 2019, this facility is expected to be the largest in Europe.
Canopy Rivers Inc. (the “Company” or “Canopy Rivers”) (RIV.V) today announced that Narbe Alexandrian has been appointed as President of the Company, effective immediately. In this role, Narbe will lead the corporate development initiatives as well as manage the day-to-day business of the Company. “I believe that the team at Canopy Rivers has developed one of the most attractive and compelling platforms in the cannabis industry today,” said Narbe Alexandrian, newly appointed President of Canopy Rivers.
Canopy Rivers Inc. (the “Company” or “Canopy Rivers”) (RIV.V) today announced its investment in Greenhouse Juice Company (“Greenhouse”), a dynamic plant-based food and beverage company. Canopy Rivers has committed $9 million in a convertible debt financing package (the “Financing”) that includes secured and unsecured debt, warrant coverage, and board representation rights. Proceeds from this financing will be used to supplement Greenhouse’s national expansion and initiatives for the development of natural health and wellness beverages infused with cannabidiol (“CBD”).
Canopy Rivers Inc. (the “Company” or “Canopy Rivers”) (RIV.V) is pleased to announce it has completed an equity investment in Headset, Inc. (“Headset”), a data and analytics service provider for the cannabis industry. “We are very excited to be diversifying our portfolio with our investment in Headset, a best-in-class technology platform delivering cannabis-related business intelligence in real-time,” said Narbe Alexandrian, VP Business Development at Canopy Rivers.
Canopy Rivers Inc. (“Canopy Rivers” or the “Company”) (RIV.V) today announced that its 49%-owned joint venture PharmHouse Inc. (“PharmHouse”) has entered into a syndicated credit facility (the “Credit Facility”) with the Bank of Montreal (“BMO”), as agent and lead lender, and with Canadian Imperial Bank of Commerce and Concentra Bank as lenders (together with BMO, the “Lenders”). Under the terms of the Credit Facility, the Lenders will provide PharmHouse up to C$80 million of secured debt financing at a rate of interest that is expected to average in the mid-to-high 5% per annum range over its three-year term.
Canopy Rivers Inc. (the “Company” or “Canopy Rivers”) (RIV.V) today announced that it has retained Hybrid Financial Ltd. (“Hybrid”), a marketing and retail distribution services company, to provide certain investor relations services. “We are confident that Hybrid will help us increase market awareness and further engage with the investment community,” said Daniel Pearlstein, EVP, Strategy at Canopy Rivers. Hybrid will be paid a monthly fee of C$14,000 and has been granted options to purchase up to 120,000 shares of the Company at a price of $3.50 per share.
Canopy Rivers Inc. (the “Company” or “Canopy Rivers”) (RIV.V) is pleased to announce that its shares have received DTC full service eligibility in the United States. The Company’s identifier is “CNPOF”.
OTCQX: TRSSF), NETA NJ LLC (“NETA”), has been selected by the State of New Jersey Department of Health to apply for final approval to operate a vertically integrated Alternative Treatment Center (ATC), which would permit it to cultivate, process and sell medical cannabis in the state. The State of New Jersey received a total of 146 applications to cultivate, process and sell medical cannabis.
Canopy Rivers Inc. (the “Company” or “Canopy Rivers”) (RIV.V) is pleased to announce that it has increased its ownership stake in CanapaR Corp. (“CanapaR Canada”), the Canadian parent corporation of CanapaR SrL (“CanapaR Italy”), an Italy-based organic hemp production and processing platform. The investment, which increases the Company’s ownership position to 49.9%, builds upon Canopy Rivers’ international expansion strategy and positions the Company to capitalize on the expected growth in demand for cannabis and CBD derivative products in the rapidly growing European cannabis market.
TORONTO , Nov. 30, 2018 /CNW/ - Canopy Growth Corporation (WEED.TO) (CGC) ("Canopy Growth") and Canopy Rivers Inc. ("Canopy Rivers") (RIV.V) are pleased to announce the closing of the previously announced restructuring transaction with TerrAscend Corp. ("TerrAscend") (CSE:TER) pursuant to which TerrAscend restructured its share capital by way of a plan of arrangement under the Business Corporations Act ( Ontario ) (the "Arrangement"). The announcement follows TerrAscend's special meeting of shareholders held on November 27, 2018 where holders of common shares in the capital of TerrAscend (the "Common Shares") voted to approve the Arrangement. To accommodate TerrAscend's strategic pursuits, while also maintaining strict compliance with industry regulations and the policies of the various securities exchanges on which they are listed, Canopy Growth and Canopy Rivers Corporation ("Rivers") agreed to restructure their investments in TerrAscend and exchange their Common Shares for exchangeable shares in the capital of TerrAscend (the "Exchangeable Shares") that will only become convertible into Common Shares following changes in U.S. federal laws regarding the cultivation, distribution or possession of marijuana, the compliance of TerrAscend with such laws and the approval of the various securities exchanges upon which Canopy Growth and Canopy Rivers are listed.